All Articles Tagged With: "Anemia"
Articles
Black Box Warning Added About Side Effects of Exjade
The FDA has announced that it is requiring a new “black box” warning to alert patients to the potential dangers of Exjade side effects, an iron-reducing medication made by Novartis AG, which could increase the risk of kidney problems, liver problems and gastrointestinal bleeding.
Side Effects of Aranesp, Procrit and Epogen Lead to New FDA Restrictions
Concerns over the increased risk of heart attacks, blood clots, tumors and death from side effects of Aranesp, Procrit and Epogen have led the FDA to restrict the prescribing of the anemia drugs under a risk evaluation and mitigation strategy (REMS).
Aranesp, Epogen and Procrit Health Risks to be Reviewed Further by FDA
The FDA indicates that it will further examine the side effects of anemia drugs, including Aranesp, Epogen and Procrit, due to the potential increased risk of heart attacks, strokes and blood clots.
Aranesp, Epogen and Procrit Blood Clot Risk Confirmed: Study
According to new research, the anti-anemia drugs Aranesp, Epogen and Procrit not only increase the risk of blood clots, but they also do not appear to be doing what they were designed to do.
FDA Recommends Test Doses to Reduce Risk of Dexferrum Allergic Reactions
Doctors should give anemic patients test doses of the iron deficiency treatment drug Dexferrum, to check for potentially deadly allergic reactions, according to a new labeling change the FDA announced Friday.
University Challenges Wrongful Death Lawsuit by Football Player’s Family
University of Central Florida (UCF) is attempting to avoid liability in a wrongful death lawsuit filed by the family of a student who died during football practice, arguing that a medical waiver he signed protects the school.
CellCept Pure Red Cell Aplasia Reports Lead to New Warnings
The FDA announced Friday that labeling for the organ transplant medication CellCept will be changed to add warnings that the drug could cause a type of anemia known as Pure Red Cell Aplasia (PRCA).
Epogen and Procrit Side Effects Linked to Death for Stroke Patients
Preliminary data from a study funded by Johnson & Johnson’s Ortho Biotech unit found that individuals who were given Procrit (which is also marketed as Epogen) following an ischemic stroke had a greater incidence of death than those who received a placebo.
